Congratulations, Summer 2022 Graduates
Congratulations to the 166 students from the Duke University School of Medicine who will graduate this summer from health professions and biomedical PhD programs.
Duke-led Center Seeks to Examine and Engineer the Microbial Communities of Indoor Spaces
New $26 million center will work to understand and engineer the microbiomes in our homes, workspaces and other built environments
DPT at APTA Annual Meeting
Duke DPT was well represented at the APTA annual meeting in Washington, DC.
Students research shines with help from pilot grants
The Duke School of Medicine Precision Genomics Collaboratory and the Office of Biomedical and Graduate Education have been providing $2,000 pilot grant opportunities three times a year for current biomedical PhD students since August 2021.
After receiving their grants, students have six months to use their funds, which could go towards research or professional development.
Jumping genes drive drug resistance of a world-wide fungal pathogen
Drug-resistant microbial pathogens — whether parasite, bacteria, virus, or fungus — are a major global challenge that can lead to limited treatment options, increased costs for resources, and higher levels of morbidity and mortality.
A Duke-led international research team has discovered one of the ways that drug resistance can develop: a process by which mobile DNA sequences called transposons trigger “hypermutation,” allowing certain genetic components to multiply unchecked.
Summer Scholars leave Duke with a once-in-a-lifetime research experience
This summer, eight scholars from across the country were paired with a faculty research mentor to learn laboratory skills, designing a research project, and effectively presenting future research.
It Doesn't Matter Much Which Fiber You Choose -- Just Get More Fiber
The human gut evolved to thrive on fermentable fibers, not bacon cheeseburgers
CRISPR Technology Demonstrates Success in Preventing and Treating COVID
In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.